Rockefeller Capital Management L.P. Immunity Bio, Inc. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $47,968 - $86,122	-8,460 Reduced 84.6%	1,540 $9,000
Q3 2021 Nov 12, 2021	SELL	$9.17 - $14.24 $917 - $1,424	-100 Reduced 0.99%	10,000 $97,000
Q2 2021 Aug 10, 2021	BUY	$13.41 - $22.4 $134,100 - $224,000	10,000 Added 10000.0%	10,100 $144,000
Q1 2021 May 11, 2021	BUY	$12.83 - $42.25 $1,283 - $4,225	100 New	100 $2,000

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.